INTERNATIONAL PATENT: SAGE THERAPEUTICS, INC. FILES APPLICATION FOR "NMDA RECEPTOR-MODULATING COMPOUNDS AND METHODS OF USE THEREOF"

GENEVA, Oct. 28 -- SAGE THERAPEUTICS, INC. (55 Cambridge ParkwayCambridge, Massachusetts 02142) filed a patent application (PCT/US2025/024685) for "NMDA RECEPTOR-MODULATING COMPOUNDS AND METHODS OF USE THEREOF" on Apr 15, 2025. With publication no. WO/2025/221731, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HILL, Matthew D. (c/o Sage Therapeutics, Inc.55 Cambridge ParkwayCambridge, Massachusetts 02142)

Abstract: Compounds are provided according to Formula (A) and pharmaceutically acceptable salts, isotopically labele...